Posted in | News | Plastics and Polymers | Business

Kemira Acquires Pulp and Paper Chemicals Business from Vulcan

May 20 2003

Related Stories

Pulp and paper chemicals manufacturer Kemira have just acquired the pulp and paper chemicals business of Vulcan Materials for US$44 million.

The acquisition strengthens Kemira’s North American presence and allows them to better serve the global pulp and paper chemicals market.

Included in the transaction are plants in North America located at: Columbus Georgia; Shreveport Louisiana and; Vancouver, British Columbia. Products such as emulsion polymers, defoamers, wet and dry strength resins and a range of other custom products are manufactured at these locations.

They will also acquire approximately 200 staff in the transaction.

For more information on the paper industry, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback